The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans
- Supplementary File 1:
PDF-Document (PDF, 3202 KiB)
Batchu, S.N.; Yerra, V.G.; Liu, Y.; Advani, S.L.; Klein, T.; Advani, A. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. Int. J. Mol. Sci. 2020, 21, 5756. https://doi.org/10.3390/ijms21165756
Batchu SN, Yerra VG, Liu Y, Advani SL, Klein T, Advani A. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. International Journal of Molecular Sciences. 2020; 21(16):5756. https://doi.org/10.3390/ijms21165756
Chicago/Turabian StyleBatchu, Sri N.; Yerra, Veera G.; Liu, Youan; Advani, Suzanne L.; Klein, Thomas; Advani, Andrew. 2020. "The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans" Int. J. Mol. Sci. 21, no. 16: 5756. https://doi.org/10.3390/ijms21165756